These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 27458549)

  • 1. Ontology-based Vaccine and Drug Adverse Event Representation and Theory-guided Systematic Causal Network Analysis toward Integrative Pharmacovigilance Research.
    He Y
    Curr Pharmacol Rep; 2016 Jun; 2(3):113-128. PubMed ID: 27458549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ontology-Based Vaccine Adverse Event Representation and Analysis.
    Xie J; He Y
    Adv Exp Med Biol; 2017; 1028():89-103. PubMed ID: 29058218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ODAE: Ontology-based systematic representation and analysis of drug adverse events and its usage in study of adverse events given different patient age and disease conditions.
    Yu H; Nysak S; Garg N; Ong E; Ye X; Zhang X; He Y
    BMC Bioinformatics; 2019 May; 20(Suppl 7):199. PubMed ID: 31074377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ontology-supported research on vaccine efficacy, safety and integrative biological networks.
    He Y
    Expert Rev Vaccines; 2014 Jul; 13(7):825-41. PubMed ID: 24909153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ontology-based collection, representation and analysis of drug-associated neuropathy adverse events.
    Guo A; Racz R; Hur J; Lin Y; Xiang Z; Zhao L; Rinder J; Jiang G; Zhu Q; He Y
    J Biomed Semantics; 2016; 7():29. PubMed ID: 27213033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Ontology of Vaccine Adverse Events (OVAE) and its usage in representing and analyzing adverse events associated with US-licensed human vaccines.
    Marcos E; Zhao B; He Y
    J Biomed Semantics; 2013 Nov; 4(1):40. PubMed ID: 24279920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linking MedDRA(®)-Coded Clinical Phenotypes to Biological Mechanisms by the Ontology of Adverse Events: A Pilot Study on Tyrosine Kinase Inhibitors.
    Sarntivijai S; Zhang S; Jagannathan DG; Zaman S; Burkhart KK; Omenn GS; He Y; Athey BD; Abernethy DR
    Drug Saf; 2016 Jul; 39(7):697-707. PubMed ID: 27003817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Towards precision informatics of pharmacovigilance: OAE-CTCAE mapping and OAE-based representation and analysis of adverse events in patients treated with cancer drugs.
    Wong MU; Racz R; Ong E; He Y
    AMIA Annu Symp Proc; 2017; 2017():1793-1801. PubMed ID: 29854250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OAE: The Ontology of Adverse Events.
    He Y; Sarntivijai S; Lin Y; Xiang Z; Guo A; Zhang S; Jagannathan D; Toldo L; Tao C; Smith B
    J Biomed Semantics; 2014; 5():29. PubMed ID: 25093068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 2012 Workshop: Vaccine and Drug Ontology in the Study of Mechanism and Effect (VDOSME 2012).
    He Y; Toldo L; Burns G; Tao C; Abernethy DR
    J Biomed Semantics; 2012 Dec; 3(1):12. PubMed ID: 23249650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Natural Language Processing (NLP) systems to annotate drug product labeling with MedDRA terminology.
    Ly T; Pamer C; Dang O; Brajovic S; Haider S; Botsis T; Milward D; Winter A; Lu S; Ball R
    J Biomed Inform; 2018 Jul; 83():73-86. PubMed ID: 29860093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ontology-based Precision Vaccinology for Deep Mechanism Understanding and Precision Vaccine Development.
    Xie J; Zi W; Li Z; He Y
    Curr Pharm Des; 2021; 27(7):900-910. PubMed ID: 33238868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disease Specific Ontology of Adverse Events: Ontology extension and adaptation for Chronic Kidney Disease.
    Kang Y; Fink JC; Doerfler R; Zhou L
    Comput Biol Med; 2018 Oct; 101():210-217. PubMed ID: 30195820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. OntoADR a semantic resource describing adverse drug reactions to support searching, coding, and information retrieval.
    Souvignet J; Declerck G; Asfari H; Jaulent MC; Bousquet C
    J Biomed Inform; 2016 Oct; 63():100-107. PubMed ID: 27369567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ontology-based systematic representation and analysis of traditional Chinese drugs against rheumatism.
    Liu Q; Wang J; Zhu Y; He Y
    BMC Syst Biol; 2017 Dec; 11(Suppl 7):130. PubMed ID: 29322929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccine and Drug Ontology Studies (VDOS 2014).
    Tao C; He Y; Arabandi S
    J Biomed Semantics; 2016; 7():6. PubMed ID: 26918107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ontology-based literature mining and class effect analysis of adverse drug reactions associated with neuropathy-inducing drugs.
    Hur J; Özgür A; He Y
    J Biomed Semantics; 2018 Jun; 9(1):17. PubMed ID: 29880031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ontology-Based Meta-Analysis of Animal and Human Adverse Events Associated With Licensed Brucellosis Vaccines.
    Xie J; Wang J; Li Z; Wang W; Pang Y; He Y
    Front Pharmacol; 2018; 9():503. PubMed ID: 29867505
    [No Abstract]   [Full Text] [Related]  

  • 19. Ontology-based systematical representation and drug class effect analysis of package insert-reported adverse events associated with cardiovascular drugs used in China.
    Wang L; Li M; Xie J; Cao Y; Liu H; He Y
    Sci Rep; 2017 Oct; 7(1):13819. PubMed ID: 29061976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signal detection of human papillomavirus vaccines using the Korea Adverse Events Reporting System database, between 2005 and 2016.
    Ran J; Yang JY; Lee JH; Kim HJ; Choi JY; Shin JY
    Int J Clin Pharm; 2019 Oct; 41(5):1365-1372. PubMed ID: 31313003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.